Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Venture Life Group PLC (GB:VLG)
LSE:VLG
Holding GB:VLG?
Track your performance easily
VLG Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range27.00p - 50.00p
Previous Close46.75p
Volume141.05K
Average Volume (3M)147.44K
Market Cap
£59.21M
Enterprise Value80.42M
Total Cash (Recent Filing)£5.63M
Total Debt (Recent Filing)£26.85M
Price to Earnings (P/E)67.0
Beta0.80
Next Earnings
Sep 19, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 24, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding125,831,530
10 Day Avg. Volume513,404
30 Day Avg. Volume147,436
Standard Deviation0.13
R-Squared0.00202
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)142.50
Price to Sales (P/S)328.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Venture Life News
PremiumCompany Announcements
Venture Life Executives Sell Shares for Taxes
PremiumCompany Announcements
Venture Life Issues New Shares Post-Executives’ Options Exercise
PremiumCompany Announcements
Venture Life Announces New Share Issuance
PremiumCompany Announcements
Slater Investments Crosses 20% Voting Rights in Venture Life
PremiumCompany Announcements
Venture Life Reports Robust UK Brand Growth
PremiumCompany Announcements
Slater Investments Ups Stake in Venture LifePremiumCompany Announcements
Venture Life Group Stake Shifts to BGF
PremiumCompany Announcements
Venture Life Announces Annual Report ReleaseOptions Prices
Currently, No data available
---
Ownership Overview
6.35%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
93.65% Public Companies and
Individual Investors
VLG FAQ
What was Venture Life Group PLC’s price range in the past 12 months?
Venture Life Group PLC lowest share price was 27.00p and its highest was 50.00p in the past 12 months.
What is Venture Life Group PLC’s market cap?
Currently, no data Available
When is Venture Life Group PLC’s upcoming earnings report date?
Venture Life Group PLC’s upcoming earnings report date is Sep 19, 2024 which is yesterday.
How were Venture Life Group PLC’s earnings last quarter?
Venture Life Group PLC released its earnings results on Apr 09, 2024. The company reported 0.019p earnings per share for the quarter, beating the consensus estimate of N/A by 0.019p.
Is Venture Life Group PLC overvalued?
According to Wall Street analysts Venture Life Group PLC’s price is currently Overvalued.
Does Venture Life Group PLC pay dividends?
Venture Life Group PLC pays a Annually dividend of 0p which represents an annual dividend yield of N/A. See more information on Venture Life Group PLC dividends here
What is Venture Life Group PLC’s EPS estimate?
Venture Life Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Venture Life Group PLC have?
Venture Life Group PLC has 126,647,710 shares outstanding.
What happened to Venture Life Group PLC’s price movement after its last earnings report?
Venture Life Group PLC reported an EPS of 0.019p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.185%.
Which hedge fund is a major shareholder of Venture Life Group PLC?
Currently, no hedge funds are holding shares in GB:VLG
---
Venture Life Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.62%
12-Months-Change
Fundamentals
Return on Equity
1.21%
Trailing 12-Months
Asset Growth
-4.62%
Trailing 12-Months
Company Description
Venture Life Group PLC
Venture Life Group PLC is an international consumer self-care company. The company focuses on developing, manufacturing and commercializing products for the aging population. Its products include Oral Healthcare, Proctology, Dermatology, Neurology, and Women's Healthcare. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements; and Development and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. It earns a vast majority of its revenue from the Development and Manufacturing segment in the United Kingdom. Geographically, it also operates in Italy, Switzerland, and other regions.
---
Technical Analysis
---